The 5-marker panel (MMP9, tumor volume, presence of brainstem compression, CSF cleft, and cystic change) exhibited the best performance (AUC5-marker = 0.95, Sensitivity 80%, Specificity 100%) (Figure 4F and Supplementary Table 8). This evidence concerns the gene MMP9 and neoplasm.